<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39358480</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2045-9769</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Cell regeneration (London, England)</Title><ISOAbbreviation>Cell Regen</ISOAbbreviation></Journal><ArticleTitle>Targeting senescent cells in aging and COVID-19: from cellular mechanisms to therapeutic opportunities.</ArticleTitle><Pagination><StartPage>20</StartPage><MedlinePgn>20</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13619-024-00201-1</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has caused a global health crisis and significant social economic burden. While most individuals experience mild or non-specific symptoms, elderly individuals are at a higher risk of developing severe symptoms and life-threatening complications. Exploring the key factors associated with clinical severity highlights that key characteristics of aging, such as cellular senescence, immune dysregulation, metabolic alterations, and impaired regenerative potential, contribute to disruption of tissue homeostasis of the lung and worse clinical outcome. Senolytic and senomorphic drugs, which are anti-aging treatments designed to eliminate senescent cells or decrease the associated phenotypes, have shown promise in alleviating age-related dysfunctions and offer a novel approach to treating diseases that share certain aspects of underlying mechanisms with aging, including COVID-19. This review summarizes the current understanding of aging in COVID-19 progression, and highlights recent findings on anti-aging drugs that could be repurposed for COVID-19 treatment to complement existing therapies.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yu</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Cell Lineage and Atlas, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Kaixuan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Cell Lineage and Atlas, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China. lin_kaixuan@gibh.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Haoyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Cell Lineage and Atlas, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Mingli</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Cell Lineage and Atlas, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xuejie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Cell Lineage and Atlas, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Cell Lineage and Atlas, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grillari</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Austrian Cluster for Tissue Regeneration, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular Biotechnology, BOKU University, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation With AUVA, 1200, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jiekai</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Cell Lineage and Atlas, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China. chen_jiekai@gibh.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>National Key R&amp;D Program of China (2021YFE0112900)</GrantID><Agency>Ministry of Science and Technology of the People's Republic of China</Agency><Country /></Grant><Grant><GrantID>National Key R&amp;D Program of China (2021YFE0112900)</GrantID><Agency>Ministry of Science and Technology of the People's Republic of China</Agency><Country /></Grant><Grant><GrantID>Basic Research Project of Guangzhou Institutes of Biomedicine</GrantID><Agency>Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences</Agency><Country /></Grant><Grant><GrantID>Health</GrantID><Agency>Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences</Agency><Country /></Grant><Grant><GrantID>Chinese Academy of Sciences (GIBHBRP23-02)</GrantID><Agency>Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences</Agency><Country /></Grant><Grant><GrantID>the Austrian Science Fund (FWF)</GrantID><Agency>Austrian Science Fund</Agency><Country /></Grant><Grant><GrantID>'Herzfelder'sche Familienstiftung project P35268-B</GrantID><Agency>Austrian Science Fund</Agency><Country /></Grant><Grant><GrantID>BMBWF</GrantID><Agency>Bundesministerium für Bildung, Wissenschaft und Forschung</Agency><Country /></Grant><Grant><GrantID>WTZ-OEAD grant (CN 04/2021)</GrantID><Agency>Bundesministerium für Bildung, Wissenschaft und Forschung</Agency><Country /></Grant><Grant><GrantID>2023B1212060050</GrantID><Agency>Science and Technology Planning Project of Guangdong Province</Agency><Country /></Grant><Grant><GrantID>2023B1212120009</GrantID><Agency>Science and Technology Planning Project of Guangdong Province</Agency><Country /></Grant><Grant><GrantID>2024A04J4199</GrantID><Agency>Guangzhou Municipal Science and Technology Project</Agency><Country /></Grant><Grant><GrantID>2021A1515111044</GrantID><Agency>Basic and Applied Basic Research Foundation of Guangdong Province</Agency><Country /></Grant><Grant><GrantID>32000414</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Cell Regen</MedlineTA><NlmUniqueID>101627311</NlmUniqueID><ISSNLinking>2045-9769</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aging</Keyword><Keyword MajorTopicYN="N">Anti-aging Therapies</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cellular Senescence</Keyword></KeywordList><CoiStatement>Dr. Jiekai Chen is a member of the Editorial Board for Cell Regeneration. He was not involved in the journal’s review of, or decisions related to, this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39358480</ArticleId><ArticleId IdType="pmc">PMC11447201</ArticleId><ArticleId IdType="doi">10.1186/s13619-024-00201-1</ArticleId><ArticleId IdType="pii">10.1186/s13619-024-00201-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, et al. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2022;399(10320):143–51. 10.1016/S0140-6736(21)01825-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8598213</ArticleId><ArticleId IdType="pubmed">34800427</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalhadi AM, Alshurafa A, Alkhatib M, Abou Kamar M, Yassin MA. Confirmed Coronavirus Disease-19 (COVID-19) in a Male with Chronic Myeloid Leukemia Complicated by Febrile Neutropenia and Acute Respiratory Distress Syndrome. Case Rep Oncol. 2020;13(2):569–77. 10.1159/000508378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7275193</ArticleId><ArticleId IdType="pubmed">32547383</ArticleId></ArticleIdList></Reference><Reference><Citation>Abruzzese E, Luciano L, D’Agostino F, Trawinska MM, Pane F, De Fabritiis P. SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection: CML and COVID-19. Mediterr J Hematol Infect Dis. 2020;12(1):e2020031. 10.4084/mjhid.2020.031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202347</ArticleId><ArticleId IdType="pubmed">32395220</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal PK, Agrawal C, Blunden G. Quercetin: Antiviral Significance and Possible COVID-19 Integrative Considerations. Nat Prod Commun. 2020;15(12):1934578X2097629. 10.1177/1934578X20976293.</Citation></Reference><Reference><Citation>Aros CJ, Vijayaraj P, Pantoja CJ, Bisht B, Meneses LK, Sandlin JM, et al. Distinct Spatiotemporally Dynamic Wnt-Secreting Niches Regulate Proximal Airway Regeneration and Aging. Cell Stem Cell. 2020;27(3):413–429.e4. 10.1016/j.stem.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484054</ArticleId><ArticleId IdType="pubmed">32721381</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia MS, Hassaballah MY, Negida A, Sebaiy MM, Ziedan NI. Bcr-abl tyrosine kinase inhibitors as candidates for the treatment of covid-19: Molecular docking, pharmacophore modeling, admet studies. Biointerface Res Appl Chem. 2022;12(3):3357–71. 10.33263/briac123.33573371.</Citation></Reference><Reference><Citation>Attiq A, Yao LJ, Afzal S, Khan MA. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19. Int Immunopharmacol. 2021;101(PB):108255. 10.1016/j.intimp.2021.108255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516728</ArticleId><ArticleId IdType="pubmed">34688149</ArticleId></ArticleIdList></Reference><Reference><Citation>Azadvari M, Haghparast A, Nakhostin-Ansari A, Emami Razavi SZ, Hosseini M. Musculoskeletal symptoms in patients with long COVID: A cross-sectional study on Iranian patients. Heliyon. 2022 Aug 1;8(8). 10.1016/j.heliyon.2022.e10148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9367176</ArticleId><ArticleId IdType="pubmed">35971463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol. 2021;12(11):571416. 10.3389/fphys.2020.571416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7835928</ArticleId><ArticleId IdType="pubmed">33510644</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker SA, Kwok S, Berry GJ, Montine TJ. Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation. PLoS One. 2021;16(2 February):1–17. 10.1371/journal.pone.0247060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7886150</ArticleId><ArticleId IdType="pubmed">33592054</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering VA, van Zon SKRR, olde Hartman TC, Rosmalen JGMM, Ballering A V., van Zon SKRR, et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022 Aug 6;400(10350):452–61. 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, et al. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020;26(7):1676–82. 10.1177/1078155220953198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7506180</ArticleId><ArticleId IdType="pubmed">32854573</ArticleId></ArticleIdList></Reference><Reference><Citation>Battinelli EM. COVID-19 concerns aggregate around platelets. Blood. 2020;136(11):1221–3. 10.1182/blood.2020007805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483434</ArticleId><ArticleId IdType="pubmed">32957116</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkel C, Cacan E. A collective analysis of lifespan-extending compounds in diverse model organisms, and of species whose lifespan can be extended the most by the application of compounds. Biogerontology. 2021;22(6):639–53. 10.1007/s10522-021-09941-y.</Citation><ArticleIdList><ArticleId IdType="pubmed">34687363</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383(25):2451–60. 10.1056/NEJMcp2009575.</Citation><ArticleIdList><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode-Böger SM, Martens-Lobenhoffer J, Täger M, Schröder H, Scalera F. Aspirin reduces endothelial cell senescence. Biochem Biophys Res Commun. 2005;334(4):1226–32. 10.1016/j.bbrc.2005.07.014.</Citation><ArticleIdList><ArticleId IdType="pubmed">16039999</ArticleId></ArticleIdList></Reference><Reference><Citation>Breen EC, Sehl ME, Shih R, Langfelder P, Wang R, Horvath S, et al. Accelerated aging with HIV begins at the time of initial HIV infection. iScience. 2022 Jul 15;25(7). 10.1016/j.isci.2022.104488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9308149</ArticleId><ArticleId IdType="pubmed">35880029</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustamante-Marin XM, Ostrowski LE. Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol. 2017;9(4):1–17. 10.1101/cshperspect.a028241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5378048</ArticleId><ArticleId IdType="pubmed">27864314</ArticleId></ArticleIdList></Reference><Reference><Citation>Calhoun C, Shivshankar P, Saker M, Sloane LB, Livi CB, Sharp ZD, et al. Senescent Cells Contribute to the Physiological Remodeling of Aged Lungs. Journals Gerontol - Ser A Biol Sci Med Sci. 2016;71(2):153–60. 10.1093/gerona/glu241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4861645</ArticleId><ArticleId IdType="pubmed">25568097</ArticleId></ArticleIdList></Reference><Reference><Citation>Camell CD, Yousefzadeh MJ, Zhu Y, Prata LGPL, Huggins MA, Pierson M, et al. Senolytics reduce coronavirus-related mortality in old mice. Science (80-). 2021;373(6552):eabe4832. 10.1126/science.abe4832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8607935</ArticleId><ArticleId IdType="pubmed">34103349</ArticleId></ArticleIdList></Reference><Reference><Citation>Caohuy H, Eidelman O, Chen T, Liu S, Yang Q, Bera A, et al. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells. Sci Rep. 2021;11(1):22195. 10.1038/s41598-021-01690-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589851</ArticleId><ArticleId IdType="pubmed">34773067</ArticleId></ArticleIdList></Reference><Reference><Citation>Capeau J. Premature Aging and Premature Age-Related Comorbidities in HIV-Infected Patients: Facts and Hypotheses. Clin Infect Dis. 2011;53(11):1127–9. 10.1093/cid/cir628.</Citation><ArticleIdList><ArticleId IdType="pubmed">21998279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMWW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;1(101):93–135. 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Liu Y, Liu Y, Zheng P. mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells. Sci Signal. 2009;2(98). 10.1126/scisignal.2000559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4020596</ArticleId><ArticleId IdType="pubmed">19934433</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J, Lee YJ, Kim JH, Kim S Il, Kim SS, Choi B-S, et al. Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19. Sci Rep. 2020;10(1):16200. 10.1038/s41598-020-72879-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530981</ArticleId><ArticleId IdType="pubmed">33004837</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Epidemiological Update(World Health Organization). 2024;1–28.</Citation></Reference><Reference><Citation>Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–92. 10.1038/s41579-018-0118-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097006</ArticleId><ArticleId IdType="pubmed">30531947</ArticleId></ArticleIdList></Reference><Reference><Citation>Delval L, Hantute-Ghesquier A, Sencio V, Flaman JM, Robil C, Angulo FS, et al. Removal of senescent cells reduces the viral load and attenuates pulmonary and systemic inflammation in SARS-CoV-2-infected, aged hamsters. Nat Aging. 2023;3(7):829–45. 10.1038/s43587-023-00442-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10353934</ArticleId><ArticleId IdType="pubmed">37414987</ArticleId></ArticleIdList></Reference><Reference><Citation>De Alencar JCG, Moreira C de L, Müller AD, Chaves CE, Fukuhara MA, Da Silva EA, et al. Double-blind, Randomized, Placebo-controlled Trial with N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021;72(11):E736–41. 10.1093/cid/ciaa1443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543361</ArticleId><ArticleId IdType="pubmed">32964918</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pierro F, Khan A, Iqtadar S, Mumtaz SU, Chaudhry MNA, Bertuccioli A, et al. Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial. Front Pharmacol. 2023;13(13):1096853. 10.3389/fphar.2022.1096853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9880293</ArticleId><ArticleId IdType="pubmed">36712674</ArticleId></ArticleIdList></Reference><Reference><Citation>Du PY, Gandhi A, Bawa M, Gromala J. The ageing immune system as a potential target of senolytics. Oxford Open Immunol. 2023;4(1). 10.1093/oxfimm/iqad004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10191675</ArticleId><ArticleId IdType="pubmed">37255929</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med. 2016;22(12):1428–38. 10.1038/nm.4222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5806691</ArticleId><ArticleId IdType="pubmed">27841876</ArticleId></ArticleIdList></Reference><Reference><Citation>Filgueira L, Larionov A, Lannes N. The influence of virus infection on microglia and accelerated brain aging. Cells. 2021;10(7). 10.3390/cells10071836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8303900</ArticleId><ArticleId IdType="pubmed">34360004</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasek NS, Kuchel GA, Kirkland JL, Xu M. Strategies for targeting senescent cells in human disease. Nat Aging. 2021;1(10):870–9. 10.1038/s43587-021-00121-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8612694</ArticleId><ArticleId IdType="pubmed">34841261</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassen NC, Papies J, Bajaj T, Emanuel J, Dethloff F, Chua RL, et al. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat Commun. 2021;12(1):3818. 10.1038/s41467-021-24007-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8217552</ArticleId><ArticleId IdType="pubmed">34155207</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordo R, Zinellu A, Eid AH, Pintus G. Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders. Molecules. 2021;26(4):856. 10.3390/molecules26040856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7915700</ArticleId><ArticleId IdType="pubmed">33562030</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D, Lim JCT, Fernaíndez SB, Joseph CR, Edwards SG, Neo ZW, et al. Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front Immunol. 2022;5:13. 10.3389/fimmu.2022.1036894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9583834</ArticleId><ArticleId IdType="pubmed">36275692</ArticleId></ArticleIdList></Reference><Reference><Citation>Grillari J, Katinger H, Voglauer R. Contributions of DNA interstrand cross-links to aging of cells and organisms. Nucleic Acids Res. 2007;35(22):7566–76. 10.1093/nar/gkm1065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2190700</ArticleId><ArticleId IdType="pubmed">18083760</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero A, Herranz N, Sun B, Wagner V, Gallage S, Guiho R, et al. Cardiac glycosides are broad-spectrum senolytics. Nat Metab. 2019;1(11):1074–88. 10.1038/s42255-019-0122-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6887543</ArticleId><ArticleId IdType="pubmed">31799499</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamidi SH, Kadamboor Veethil S, Hamidi SH. Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective. Pharmacol Reports. 2021;73(3):712–27. 10.1007/s43440-021-00255-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057922</ArticleId><ArticleId IdType="pubmed">33880743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hari P, Millar FR, Tarrats N, Birch J, Quintanilla A, Rink CJ, et al. The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype. Sci Adv. 2019;5(6):1–14. 10.1126/sciadv.aaw0254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551188</ArticleId><ArticleId IdType="pubmed">31183403</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris E. Most COVID-19 Deaths Worldwide Were Among Older People. JAMA. 2023;329(9):704–704. 10.1001/jama.2023.1554.</Citation><ArticleIdList><ArticleId IdType="pubmed">36790826</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Cai S, Feng H, Cai B, Lin L, Mai Y, et al. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients. Protein Cell. 2020;11(9):680–7. 10.1007/s13238-020-00752-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7363016</ArticleId><ArticleId IdType="pubmed">32671793</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR. In vivo differentiation potential of tracheal basal cells: Evidence for multipotent and unipotent subpopulations. Am J Physiol - Lung Cell Mol Physiol. 2004;286(4 30–4):643–9. 10.1152/ajplung.00155.2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">12871857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol. 2008;8(12):923–34. 10.1038/nri2449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2814543</ArticleId><ArticleId IdType="pubmed">19029988</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, Pão CRR, et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020;136(11):1330–41. 10.1182/blood.2020007252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483437</ArticleId><ArticleId IdType="pubmed">32678428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou X, Wang G, Fan W, Chen X, Mo C, Wang Y, et al. T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19. Int J Infect Dis. 2021;113:308–17. 10.1016/j.ijid.2021.10.033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8530772</ArticleId><ArticleId IdType="pubmed">34688948</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain A, Byrareddy SN. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19. Chem Biol Interact. 2020;331:109282. 10.1016/j.cbi.2020.109282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536130</ArticleId><ArticleId IdType="pubmed">33031791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamyshnyi O, Matskevych V, Lenchuk T, Strilbytska O, Storey K, Lushchak O. Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential. Biomed Pharmacother. 2021;144(June):112230. 10.1016/j.biopha.2021.112230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8492612</ArticleId><ArticleId IdType="pubmed">34628168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotton DN, Morrisey EE. Lung regeneration: Mechanisms, applications and emerging stem cell populations. Nat Med. 2014;20(8):822–32. 10.1038/nm.3642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4229034</ArticleId><ArticleId IdType="pubmed">25100528</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagoumtzi SM, Chondrogianni N. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases. Free Radic Biol Med. 2021;171(January):169–90. 10.1016/j.freeradbiomed.2021.05.003.</Citation><ArticleIdList><ArticleId IdType="pubmed">33989756</ArticleId></ArticleIdList></Reference><Reference><Citation>Lally MA, Tsoukas P, Halladay CW, O’Neill E, Gravenstein S, Rudolph JL. Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2. J Am Med Dir Assoc. 2021;22(1):193–8. 10.1016/j.jamda.2020.10.031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7586924</ArticleId><ArticleId IdType="pubmed">33232684</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature. 2021;599(7884):283–9. 10.1038/s41586-021-03995-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">34517409</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Wang D, Guo J, et al. COVID-19 in persons with chronic myeloid leukaemia. Leukemia. 2020;34:1799–804. 10.1038/s41375-020-0853-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233329</ArticleId><ArticleId IdType="pubmed">32424293</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020;26(6):842–4. 10.1038/s41591-020-0901-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243–78. 10.1016/j.cell.2022.11.001.</Citation><ArticleIdList><ArticleId IdType="pubmed">36599349</ArticleId></ArticleIdList></Reference><Reference><Citation>Lushchak O, Schosserer M, Grillari J. Senopathies—Diseases Associated with Cellular Senescence. Biomolecules. 2023;13(6):1–10. 10.3390/biom13060966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10296713</ArticleId><ArticleId IdType="pubmed">37371545</ArticleId></ArticleIdList></Reference><Reference><Citation>Maison DP, Deng Y, Gerschenson M. SARS-CoV-2 and the host-immune response. Front Immunol. 2023;14(June):1–9. 10.3389/fimmu.2023.1195871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10315470</ArticleId><ArticleId IdType="pubmed">37404823</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannick JB, Teo G, Bernardo P, Quinn D, Russell K, Klickstein L, et al. Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials. Lancet Heal Longev. 2021;2(5):e250–62. 10.1016/S2666-7568(21)00062-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8102040</ArticleId><ArticleId IdType="pubmed">33977284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashayekhi-Sardoo H, Hosseinjani H. A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19. J Basic Clin Physiol Pharmacol. 2022;33(1):17–25. 10.1515/jbcpp-2020-0495.</Citation><ArticleIdList><ArticleId IdType="pubmed">34218545</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattila E, Marttila H, Sahlberg N, Kohonen P, Tähtinen S, Halonen P, et al. Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase. BMC Cancer. 2010;10(May 2014). 10.1186/1471-2407-10-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820462</ArticleId><ArticleId IdType="pubmed">20055993</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrikaki M, Lee JD, Solomon IH, Slack FJ. Severe COVID-19 is associated with molecular signatures of aging in the human brain. Nat Aging. 2022;2(12):1130–7. 10.1038/s43587-022-00321-w.</Citation><ArticleIdList><ArticleId IdType="pubmed">37118539</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeever V. Long covid and myalgic encephalomyelitis/chronic fatigue syndrome are overlapping conditions. BMJ. 2024;18:384. 10.1136/bmj.q613.</Citation><ArticleIdList><ArticleId IdType="pubmed">38499289</ArticleId></ArticleIdList></Reference><Reference><Citation>Minois N. Molecular Basis of the ‘Anti-Aging’’ Effect of Spermidine and Other Natural Polyamines - A Mini-Review’. Gerontology. 2014;60(4):319–26. 10.1159/000356748.</Citation><ArticleIdList><ArticleId IdType="pubmed">24481223</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed-Hussein AAR, Aly KME, Ibrahim M-EAA. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy? Med Hypotheses. 2020;144:109975. 10.1016/j.mehy.2020.109975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834233</ArticleId><ArticleId IdType="pubmed">32531536</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J. 2022;19(1):1–15. 10.1186/s12985-022-01814-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mylonas A, O’Loghlen A. Cellular Senescence and Ageing: Mechanisms and Interventions. Front Aging. 2022;3(March):1–10. 10.3389/fragi.2022.866718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9261318</ArticleId><ArticleId IdType="pubmed">35821824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogrodnik M, Carlos Acosta J, Adams PD, d’Adda di Fagagna F, Baker DJ, Bishop CL, et al. Guidelines for minimal information on cellular senescence experimentation in vivo. Cell. 2024;187(16):4150–75. 10.1016/j.cell.2024.05.059.</Citation><ArticleIdList><ArticleId IdType="pubmed">39121846</ArticleId></ArticleIdList></Reference><Reference><Citation>Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J. Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A. 2009;106(40):17031–6. 10.1073/pnas.0905299106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2761322</ArticleId><ArticleId IdType="pubmed">19805069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Montero P, Londoño-Vallejo A, Vernot JP. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Commun Signal. 2017;15(1):1–18. 10.1186/s12964-017-0172-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5418812</ArticleId><ArticleId IdType="pubmed">28472950</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne TF, Veigulis ZP, Arreola DM, Mahajan SM, Röösli E, Curtin CM. Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration. Den Uil C, editor. PLoS One. 2021;16(2):e0246825. 10.1371/journal.pone.0246825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877611</ArticleId><ArticleId IdType="pubmed">33571280</ArticleId></ArticleIdList></Reference><Reference><Citation>Padki MM, Stambler I. Targeting Aging with Metformin (TAME). In: Gu D, Dupre ME, editors. Encyclopedia of Gerontology and Population Aging. Cham: Springer International Publishing; 2021. p. 4908–10. 10.1007/978-3-030-22009-9_400.</Citation></Reference><Reference><Citation>Pastor-Fernández A, Bertos AR, Sierra-Ramírez A, Del Moral-Salmoral J, Merino J, De Ávila AI, et al. Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice. Aging Cell. 2023;22(3):e13771. 10.1111/acel.13771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10014049</ArticleId><ArticleId IdType="pubmed">36704839</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MA, Knauer MJ, Nicholson M, Daley M, Van Nynatten LR, Martin C, et al. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol Med. 2022;28(1):1–12. 10.1186/s10020-022-00548-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, et al. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021;224(11):1839. 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard BS, BLANCOl JC, Pollard JR, Care C. Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy. In Vivo (Brooklyn). 2020;34(6):3723–30. 10.21873/invivo.12221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7811644</ArticleId><ArticleId IdType="pubmed">33144490</ArticleId></ArticleIdList></Reference><Reference><Citation>Rad AN, Grillari J. Current senolytics: Mode of action, efficacy and limitations, and their future. Mech Ageing Dev. 2023;2024(217):111888. 10.1016/j.mad.2023.111888.</Citation><ArticleIdList><ArticleId IdType="pubmed">38040344</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajeevan MS, Murray J, Oakley L, Lin JMS, Unger ER. Association of chronic fatigue syndrome with premature telomere attrition. J Transl Med. 2018;16(1):1–11. 10.1186/s12967-018-1414-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830066</ArticleId><ArticleId IdType="pubmed">29486769</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea D, Mauro MJ, Cortes JE, Jiang Q, Pagnano KB, Ongondi M, et al. COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study. Blood. 2020;136(Supplement 1):46–7. 10.1182/blood-2020-140161.</Citation></Reference><Reference><Citation>Saygili ES, Karakiliç E, Mert E, Şener A, Mirci A. Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period. Irish J Med Sci (1971 -). 2022;191(2):569–75. 10.1007/s11845-021-02823-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553499</ArticleId><ArticleId IdType="pubmed">34713419</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, Lee S. COVID-19 and cellular senescence. Nat Rev Immunol. 2023;23(4):251–63. 10.1038/s41577-022-00785-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9533263</ArticleId><ArticleId IdType="pubmed">36198912</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider JL, Rowe JH, Garcia-de-Alba C, Kim CF, Sharpe AH, Haigis MC. The aging lung: Physiology, disease, and immunity. Cell. 2021;184(8):1990–2019. 10.1016/j.cell.2021.03.005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8052295</ArticleId><ArticleId IdType="pubmed">33811810</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1(3):253–60. 10.2147/ciia.2006.1.3.253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2695176</ArticleId><ArticleId IdType="pubmed">18046878</ArticleId></ArticleIdList></Reference><Reference><Citation>Balraj Singh, Sarah Ayad, Parminder Kaur, Vinod Kumar, Sachin Gupta, Michael Maroules. COVID-19 Induced Pancytopenia in a Major Molecular Response CML patient on Dasatinib: A Case Report and Review of Literature. Eur J Case Reports Intern Med. 2021;(LATEST ONLINE):10–3. 10.12890/2021_002233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875585</ArticleId><ArticleId IdType="pubmed">33585346</ArticleId></ArticleIdList></Reference><Reference><Citation>Starke KR, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A. The isolated effect of age on the risk of COVID-19 severe outcomes: A systematic review with meta-analysis. BMJ Glob Heal. 2021;6(12):1–12. 10.1136/bmjgh-2021-006434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8678541</ArticleId><ArticleId IdType="pubmed">34916273</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong R, Miller RA, Astle CM, Floyd RA, Flurkey K, Hensley KL, et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell. 2008;7(5):641–50. 10.1111/j.1474-9726.2008.00414.x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2695675</ArticleId><ArticleId IdType="pubmed">18631321</ArticleId></ArticleIdList></Reference><Reference><Citation>Suárez-Reyes A, Villegas-Valverde CA. Implications of low-grade inflammation in SARS-CoV-2 immunopathology. MEDICC Rev. 2021;23(2):42–54. 10.37757/MR2021.V23.N2.4.</Citation><ArticleIdList><ArticleId IdType="pubmed">33974614</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Qin H, Zhang H, Feng X, Yang L, Hou DX, et al. Fisetin inhibits inflammation and induces autophagy by mediating PI3K/AKT/mTOR signaling in LPS-induced RAW264.7 cells. Food Nutr Res. 2021;65(7):1–19. 10.29219/fnr.v65.6355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009086</ArticleId><ArticleId IdType="pubmed">33841067</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFPP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363–74. 10.1038/s41577-020-0311-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Terlecki-Zaniewicz L, Lämmermann I, Latreille J, Bobbili MR, Pils V, Schosserer M, et al. Small extracellular vesicles and their miRNA cargo are anti-apoptotic members of the senescence-associated secretory phenotype. Aging (Albany NY). 2018;10(5):1103–32. 10.18632/aging.101452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5990398</ArticleId><ArticleId IdType="pubmed">29779019</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilley AE, Walters MS, Shaykhiev R, Crystal RG. Cilia dysfunction in lung disease. Annu Rev Physiol. 2015;77:379–406. 10.1146/annurev-physiol-021014-071931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4465242</ArticleId><ArticleId IdType="pubmed">25386990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomazou M, Bourdakou MM, Minadakis G, Zachariou M, Oulas A, Karatzas E, et al. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19. Brief Bioinform. 2021;22(6):bbab114. 10.1093/bib/bbab114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135326</ArticleId><ArticleId IdType="pubmed">34009288</ArticleId></ArticleIdList></Reference><Reference><Citation>Triana-Martínez F, Picallos-Rabina P, Da Silva-Álvarez S, Pietrocola F, Llanos S, Rodilla V, et al. Identification and characterization of Cardiac Glycosides as senolytic compounds. Nat Commun. 2019;10(1):4731. 10.1038/s41467-019-12888-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6803708</ArticleId><ArticleId IdType="pubmed">31636264</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji S, Minami S, Hashimoto R, Konishi Y, Suzuki T, Kondo T, et al. SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response. Nat Aging. 2022;2(2):115–24. 10.1038/s43587-022-00170-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10154207</ArticleId><ArticleId IdType="pubmed">37117754</ArticleId></ArticleIdList></Reference><Reference><Citation>Usman A, Bliden KP, Cho A, Walia N, Jerjian C, Singh A, et al. Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes. J Thromb Thrombolysis. 2022;53(2):363–71. 10.1007/s11239-022-02631-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8764325</ArticleId><ArticleId IdType="pubmed">35041121</ArticleId></ArticleIdList></Reference><Reference><Citation>V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155–70. 10.1038/s41579-020-00468-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoorn BP, Evans TK, Hanson GJ, Zhu Y, Langhi Prata LGP, Pignolo RJ, et al. Fisetin for COVID-19 in skilled nursing facilities: Senolytic trials in the COVID era. J Am Geriatr Soc. 2021;69(11):3023–33. 10.1111/jgs.17416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447437</ArticleId><ArticleId IdType="pubmed">34375437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Han J, Elisseeff JH, Demaria M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat Rev Mol Cell Biol. 2024; 10.1038/s41580-024-00727-x.</Citation><ArticleIdList><ArticleId IdType="pubmed">38654098</ArticleId></ArticleIdList></Reference><Reference><Citation>Weichhart T. MTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review. Gerontology. 2018;64(2):127–34. 10.1159/000484629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6089343</ArticleId><ArticleId IdType="pubmed">29190625</ArticleId></ArticleIdList></Reference><Reference><Citation>Weilner S, Schraml E, Wieser M, Messner P, Schneider K, Wassermann K, et al. Secreted microvesicular miR-31 inhibits osteogenic differentiation of mesenchymal stem cells. Aging Cell. 2016;15(4):744–54. 10.1111/acel.12484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4933673</ArticleId><ArticleId IdType="pubmed">27146333</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS One. 2020;15(7):e0235458. 10.1371/journal.pone.0235458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347130</ArticleId><ArticleId IdType="pubmed">32645044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Pitcher LE, Prahalad V, Niedernhofer LJ, Robbins PD. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J. 2023; 10.1111/febs.16350.</Citation><ArticleIdList><ArticleId IdType="pubmed">35015337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14(4):644–58. 10.1111/acel.12344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4531078</ArticleId><ArticleId IdType="pubmed">25754370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H, Dai HM, Ling YY, Stout MB, et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell. 2016;15(3):428–35. 10.1111/acel.12445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854923</ArticleId><ArticleId IdType="pubmed">26711051</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinatizadeh MR, Zarandi PK, Ghiasi M, Kooshki H, Mohammadi M, Amani J, et al. Immunosenescence and inflamm-ageing in COVID-19. Ageing Res Rev. 2022;2023(84):101818. 10.1016/j.arr.2022.101818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9741765</ArticleId><ArticleId IdType="pubmed">36516928</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>